Pseudallescheriasis in the 21st century

References

• Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10, 48–66 (2004).
   PubMed Web of Science ®Google Scholar
• Husain S, Alexander BD, Munoz P et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin. Infect. Dis. 37, 221–229 (2003).
   PubMed Web of Science ®Google Scholar
• Hospenthal DR. Agents of mycetoma. In: Principles and Practice of Infectious Diseases (Sixth Edition). Mandell GL, Bennett JE, Dolin R (Eds). Elsevier Churchill Livingstone, PA, USA, 2991–2995 (2005).
   Google Scholar
• Ajello L. The isolation of Allescheria boydii shear, an etiologic agent of mycetomas, from soil. Am. J. Trop. Med. 1, 227–238 (1952).
   PubMed Web of Science ®Google Scholar
• Boyd MF, Crutchfield ED. A contribution to the study of mycetoma in North America. Am. J. Trop. Med. 1, 215–289 (1921).
   Google Scholar
• Emmons CW. Allescheria boydii and Monosporium apiospermum. Mycologia 36, 188–193 (1944).
   Google Scholar
• Ajello L, Zeidberg LD. Isolation of Histoplasma capsulatum and Allescheria boydii from soil. Science 113, 662–663 (1951).
   PubMed Web of Science ®Google Scholar
• Green WO, Adams TE. Mycetoma in the United States. A review and report of seven additional cases. Am. J. Clin. Pathol. 42, 75–91 (1964).
   PubMed Web of Science ®Google Scholar
• Dowding ES. Monosporium apiospermum, a fungus causing madura foot in Canada. Can. Med. Assoc. J. 33, 28–32 (1935).
   PubMedGoogle Scholar
• Travis LB, Roberts GD, Wilson WR. Clinical significance of Pseudallescheria boydii: a review of 10 years’ experience. Mayo. Clin. Proc.60, 531–537 (1985).
   PubMed Web of Science ®Google Scholar
• Creitz J, Harris HW. Isolation of Allescheria boydii from sputum. Am. Rev. Tuberc. 71, 126–130 (1955).
   PubMedGoogle Scholar
• Arnett JC, Hatch HB. Pulmonary allescheriasis, report of a case and review of the literature. Arch. Intern. Med. 135, 1250–1253 (1975).
   PubMedGoogle Scholar
• Winston DJ, Jordan MC, Rhodes J. Allescheria boydii infections in the immunosuppressed host. Am. J. Med. 63, 830–835 (1977).
   PubMed Web of Science ®Google Scholar
• Vartivarian SE, Anaissie EJ, Bodey GP. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin. Infect. Dis. 17(Suppl. 2), S487–S491 (1993).
   PubMed Web of Science ®Google Scholar
• Tadros TS, Workowski KA, Siegel RJ, Hunter S, Schwartz DA. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis. Hum. Pathol. 29, 1266–1272 (1998).
   PubMed Web of Science ®Google Scholar
• Drouhet E. Historical introduction: evolution of knowledge of the fungi and mycoses from Hippocrates to the twenty-first century. In: Topley & Wilson’s Microbiology and Microbial Infections (Ninth Edition, Volume 4). Collier L, Balows A, Sussman M (Eds). Arnold, London, UK, 3–42 (1998).
   Google Scholar
• Hospenthal DR, Bennett JE. Uncommon fungi. In: Principles and Practice of Infectious Diseases (Sixth Edition). Mandell GL, Bennett JE, Dolin R (Eds). Elsevier Churchill Livingstone, PA, USA, 3068–3079 (2005).
   Google Scholar
• Arnett JC, Beuchner HA, Hatch HB. Monosporosis vs. allescheriasis. Chest 68, 601 (1975).
   PubMed Web of Science ®Google Scholar
• Hay RJ. Agents of eumycotic mycetomas. In: Topley & Wilson’s Microbiology and Microbial Infections (Ninth Edition, Volume 4). Collier L, Balows A, Sussman M (Eds). Arnold, London, UK, 487–496 (1998).
   Google Scholar
• Larone DH. Medically Important Fungi: A Guide to Identification (Second Edition). Elsevier, NY, USA (1987).
   Google Scholar
• McGinnis MR, Padhye AA. Fungi causing eumycotic mycetoma. In: Manual of Clinical Microbiology (Eighth Edition). Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (Eds). ASM Press, Washington DC, USA, 1848–1856 (2003).
   Google Scholar
• Rippon JW. Medical Mycology (Third Edition). WB Saunders Company, PA, USA, 651–680 (1988).
   Google Scholar
• de Hoog GS, Marvin-Sikkema FD, Lahpoor GA, Gottschall JC, Prins RA, Gueho E. Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolificans. Mycoses 37, 71–78 (1994).
   PubMed Web of Science ®Google Scholar
• Cooke WB, Kabler P. Isolation of potentially pathogenic fungi from polluted water and sewage. Public Health Rep.70, 689–694 (1955).
   PubMed Web of Science ®Google Scholar
• Bell RG. The development of beef cattle manure of Petriellidium boydii (Shear) Malloch, a potential pathogen for man and cattle. Can. J. Microbiol. 22, 552–556 (1976).
   PubMed Web of Science ®Google Scholar
• Dabrowa N, Landau JW, Newcomer VD. A survey of tide-washed coastal areas of southern California for fungi potentially pathogenic to man. Mycopathol. Mycol. Appl. 15, 136–150 (1964).
   Google Scholar
• Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia 106, 13–22 (1989).
   PubMed Web of Science ®Google Scholar
• Beguin H, Nolard N. Mould biodiversity in homes: air and surface analysis of 130 dwellings. Aerobiologia 10, 157–166 (1994).
   Google Scholar
• Rainer GS, de Hoog GS, Wedde M, Graser Y, Gilges S. Molecular variability of Pseudallescheria boydii, a neurotropic opportunist. J. Clin. Microbiol. 38, 3267–3273 (2000).
   PubMed Web of Science ®Google Scholar
• Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin. Infect. Dis. 32, 1329–1324 (2001).
   Google Scholar
• Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34, 909–917 (2002).
   PubMed Web of Science ®Google Scholar
• Husain S, Munoz P, Forrest G et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact on antifungal agent therapy on outcome. Clin. Infect. Dis. 40, 89–99 (2005).
   PubMed Web of Science ®Google Scholar
• Kanafani ZA, Comair Y, Kanj SS. Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review. Eur. J. Clin. Microbiol. Infect. Dis. 23, 836–840 (2004).
   PubMed Web of Science ®Google Scholar
• Talbot TR, Hatcher J, Davis SF, Pierson RN, Barton R, Dummer S. Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient. Transplantation 74, 1645–1647 (2002).
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Sasaoka R, Kawaguchi M et al. Scedosporium apiospermum skin infection: a case report and review of the literature. J. Am. Acad. Dermatol. 39, 498–500 (1998).
   PubMed Web of Science ®Google Scholar
• Posteraro P, Frances C, Didona B, Dorent R, Posteraro B, Fadda G. Persistent subcutaneous Scedosporium apiospermum infection. Eur. J. Dermatol.13, 603–605 (2003).
   PubMed Web of Science ®Google Scholar
• Nesky MA, McDougal EC, Peacock JE. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin. Infect. Dis. 31, 673–677 (2000).
   PubMed Web of Science ®Google Scholar
• Wu Z, Ying H, Yiu S, Irvine J, Smith R. Fungal keratitis caused by Scedosporium apiospermum: report of two cases and review of treatment. Cornea 21, 519–523 (2002).
   PubMed Web of Science ®Google Scholar
• Grigg AP, Phillips P, Durham S, Shepherd JD. Recurrent Pseudallescheria boydii sinusitis in acute leukemia. Scand. J. Infect. Dis. 25, 263–267 (1993).
   PubMed Web of Science ®Google Scholar
• Tirado-Miranda R, Solera-Santos J, Brasero JC, Haro-Estarriol M, Cascales-Sanchez P, Igualada JB. Septic arthritis due to Scedosporium apiospermum: case report and review. J. Infect. 43, 210–212 (2001).
   PubMed Web of Science ®Google Scholar
• Piper JP, Golden J, Brown D, Broestler J. Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole. Pediatr. Infect. Dis. J. 9, 674–675 (1990).
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl. Infect. Dis. 1, 247–261 (1999).
   PubMedGoogle Scholar
• Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudallescheria boydii (anamorph Scedosporium apiospermum) infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 81, 333–348 (2002).
   PubMed Web of Science ®Google Scholar
• Khurshid A, Barnett VT, Sekosan M, Ginzburg AS, Onal E. Disseminated Pseudallescheria boydii infection in a nonimmunocompromised host. Chest 116, 572–574 (1999).
   PubMed Web of Science ®Google Scholar
• O’Bryan TA, Browne FA, Schonder JF. Scedosporium apiospermum (Pseudallescheria boydii) endocarditis. J. Infect. 44, 189–192 (2002).
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Roilides E, Lyman CA et al. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury. Infect. Immun. 71, 6472–6478 (2003).
   PubMed Web of Science ®Google Scholar
• Scherr GR, Evans SG, Kiyabu MT, Klatt EC. Pseudallescheria boydii infection in the acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med.116, 535–536 (1992).
   PubMed Web of Science ®Google Scholar
• Jabado N, Casanova JL, Haddad E et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin. Infect. Dis. 27, 1437–1441 (1998).
   PubMed Web of Science ®Google Scholar
• Phillips P, Forbes JC, Speert DP. Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: response to γ-interferon plus antifungal chemotherapy. Pediatr. Infect. Dis. J. 10, 536–539 (1991).
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Lutsar I, Driscoll T et al. Voriconazole in the treatment of aspergillosis, scedosporiasis, and other fungal infections in children. Pediatr. Infect. Dis. J. 21, 240–248 (2002).
   PubMed Web of Science ®Google Scholar
• Munoz P, Marin M, Tornero P, Martin Rabadan PM, Rodriguez-Creixems M, Bouza E. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin. Infect. Dis. 31, 1499–1501 (2000).
   PubMed Web of Science ®Google Scholar
• Miller MA, Greenberger PA, Amerian R et al. Allergic bronchopulmonary mycosis caused by Pseudallescheria boydii. Am. Rev. Respir. Dis. 148, 810–812 (1993).
   PubMedGoogle Scholar
• Mesnard R, Lamy T, Dauriac C, Le Prise PY. Lung abscess due to Pseudallescheria boydii in the course of acute leukemia: report of a case and review of the literature. Acta Haematol.87, 78–82 (1992).
   PubMed Web of Science ®Google Scholar
• Williamson EC, Speers D, Arthur IH, Harnett G, Ryan G, Inglis TJ. Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease. J. Clin. Microbiol. 39, 47–50 (2001).
   PubMed Web of Science ®Google Scholar
• Cimon B, Carrere J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 19, 53–56 (2000).
   PubMed Web of Science ®Google Scholar
• Bouza E, Munoz P. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin. Microbiol. Infect. 10, 76–85 (2004).
   PubMed Web of Science ®Google Scholar
• Messori A, Lanza C, De Nicola M et al. Mycotic aneurysms as lethal complication of brain pseudallescheriasis in a near-drowned child: a CT demonstration. Am. J. Neuroradiol. 23, 1697–1699 (2002).
   PubMed Web of Science ®Google Scholar
• Kershaw P, Freeman R, Templeton D et al. Pseudallescheria boydii infection of the central nervous system. Arch. Neurol. 47, 468–472 (1990).
   PubMedGoogle Scholar
• Kowacs PA, Soares Silvado CE, Monteiro de Almeida S et al. Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factors. J. Clin. Pathol. 57, 205–207 (2004).
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi MG, Pizzo PA. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob. Agents Chemother. 39, 1361–1364 (1995).
   PubMed Web of Science ®Google Scholar
• Groll AH, Walsh TJ. Antifungal chemotherapy: advances and perspectives. Swiss Med. Wkly132, 303–311 (2002).
   PubMed Web of Science ®Google Scholar
• Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ. Treatment of Scedosporium apiospermum brain abscess with posaconazole. Clin. Infect. Dis. 34, 1648–1650 (2002).
   PubMed Web of Science ®Google Scholar
• Danaher PJ, Walter EA. Successful treatment of chronic meningitis caused by Scedosporium apiospermum with oral voriconazole. Mayo. Clin. Proc.79, 707–708 (2004).
   PubMed Web of Science ®Google Scholar
• Ginter G, Petutsching B, Pierer G et al. Case report: atypical cutaneous pseudallescheriosis refractory to antifungal agents. Mycoses 42, 507–511 (1999).
   PubMed Web of Science ®Google Scholar
• Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs 64, 1997–2020 (2004).
   PubMed Web of Science ®Google Scholar
• Meletiadis J, Meis JF, Mouton JW et al. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob. Agents Chemother. 46, 62–68 (2002).
   PubMed Web of Science ®Google Scholar
• Capilla J, Serena C, Pastor FJ, Ortoneda M, Guarro J. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob. Agents Chemother. 47, 3976–3978 (2003).
   PubMed Web of Science ®Google Scholar
• Girmenia C, Luzi G, Monaco M, Martino P. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J. Clin. Microbiol. 36, 1436–1438 (1998).
   PubMed Web of Science ®Google Scholar
• Poza G, Montoya J, Redondo C et al. Meningitis caused by Pseudallescheria boydii treated with voriconazole. Clin. Infect. Dis. 30, 981–982 (2000).
   PubMed Web of Science ®Google Scholar
• Klopfenstein KJ, Rosselet R, Termuhlen A, Powell D. Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation. Med. Pediatr. Oncol.41, 494–495 (2003).
   PubMedGoogle Scholar
• Perlroth MG, Miller J. Pseudallescheria boydii pneumonia and empyema: a rare complication of heart transplantation cured with voriconazole. J. Heart Lung Transplant. 23, 647–649 (2004).
   PubMed Web of Science ®Google Scholar
• Bosma F, Voss A, van Hamersvelt HW et al. Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole. Clin. Microbiol. Infect. 9, 750–753 (2003).
   PubMed Web of Science ®Google Scholar
• Schaenman JM, DiGiulio DB, Mirels LF et al. Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy. J. Clin. Microbiol. 43, 973–977 (2005).
   PubMed Web of Science ®Google Scholar
• Fortun J, Martin-Davila P, Sanchez MA et al. Voriconazole in the treatment of invasive mold infections in transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 22, 408–413 (2003).
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Pappas P, Winston DJ et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N. Engl. J. Med. 346, 225–234 (2002).
   PubMed Web of Science ®Google Scholar
• Gonzalez GM, Tijerina R, Najvar LK et al. Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays. Antimicrob. Agents Chemother. 47, 1436–1438 (2003).
   PubMed Web of Science ®Google Scholar
• Minassian B, Huczko E, Washo T, Bonner D, Fung-Tome J. In vitro activity of ravuconazole against Zygomycetes, Scedosporium, and Fusarium isolates. Clin. Microbiol. Infect. 9, 1250–1252 (2003).
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY-303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36, 2950–2956 (1998).
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Marco F, Messer SA, Jones RN. In vitro activity of two echinocandin derivatives, LY-303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn. Microbiol. Infect. Dis. 30, 251–255 (1998).
   PubMed Web of Science ®Google Scholar
• Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis. 32, 358–366 (2001).
   PubMed Web of Science ®Google Scholar
• Wingard JR. The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr. Opin. Oncol. 17, 89–92 (2005).
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 8, 408–415 (2002).
   Google Scholar
• Bohme A, Ruhnke M, Buchheidt D et al. Treatment of fungal infections in hematology and oncology: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGIHO). Ann. Hematol. 82(Suppl. 2), S133–S140 (2003).
   Google Scholar
• Walsh TJ, Teppler H, Donowitz GR et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N. Engl. J. Med. 351, 1391–1402 (2004).
   PubMed Web of Science ®Google Scholar
• Wingard JR. Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation. Clin. Infect. Dis. 39, S176–S180 (2004).
   PubMedGoogle Scholar
• Vigouroux S, Morin O, Moreau P et al. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin. Infect. Dis. 40, E35–E37 (2005).
   PubMed Web of Science ®Google Scholar
• Klastersky J. Antifungal therapy in patients with fever and neutropenia – more rational and less empirical? N. Engl. J. Med. 351, 1445–1447 (2004).
   PubMed Web of Science ®Google Scholar
• Wedde M, Muller D, Tintelnot K, de Hoog GS, Stahl U. PCR-based identification of clinically relevant Pseudallescheria/Scedosporium strains. Med. Mycol. 36, 61–67 (1998).
   PubMed Web of Science ®Google Scholar
• de Aguirre L, Hurst SF, Choi JS, Shin JH, Hinrikson HP, Morrison CJ. Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay. J. Clin. Microbiol. 42, 3495–3504 (2004).
   PubMed Web of Science ®Google Scholar
• Pinto MR, Mulloy B, Haido RM, Travassos LR, Barreto Bergter E. A peptidorhamnomman from the mycelium of Pseudallescheria boydii is a potential diagnostic antigen of this emerging human pathogen. Microbiology 147, 1499–1506 (2001).
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 4, 349–357 (2004).
   PubMed Web of Science ®Google Scholar
• Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin. Infect. Dis. 39, S32–S37 (2004).
   PubMed Web of Science ®Google Scholar
• Powers JH. Considerations in clinical trials of combination antifungal therapy. Clin. Infect. Dis. 39, S228–S235 (2004).
   Google Scholar
• Kullberg BJ, Oude Lashoff AM, Netea MG. Design of efficacy trials of cytokines in combination with antifungal drugs. Clin. Infect. Dis. 39, S218–S223 (2004).
   Web of Science ®Google Scholar